KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Interest Coverage Ratio: 2010-2025

Historic Interest Coverage Ratio for Emergent BioSolutions (EBS) over the last 13 years, with Sep 2025 value amounting to 5.03.

  • Emergent BioSolutions' Interest Coverage Ratio fell 35.24% to 5.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.99, marking a year-over-year increase of 208.68%. This contributed to the annual value of -1.53 for FY2024, which is 81.47% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Interest Coverage Ratio of 5.03 as of Q3 2025, which was up 4,523.97% from 0.11 recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Interest Coverage Ratio registered a high of 31.87 during Q4 2021, and its lowest value of -12.29 during Q3 2023.
  • Its 3-year average for Interest Coverage Ratio is -2.19, with a median of -0.64 in 2024.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first soared by 904.18% in 2021, then slumped by 1,284.87% in 2022.
  • Over the past 5 years, Emergent BioSolutions' Interest Coverage Ratio (Quarterly) stood at 31.87 in 2021, then tumbled by 113.56% to -4.32 in 2022, then spiked by 53.28% to -2.02 in 2023, then spiked by 68.20% to -0.64 in 2024, then plummeted by 35.24% to 5.03 in 2025.
  • Its Interest Coverage Ratio was 5.03 in Q3 2025, compared to 0.11 in Q2 2025 and 3.39 in Q1 2025.